加速内体逃逸的拼接切换寡核酸使得有效的肝脏拼接纠正
Silvia Weiss1, Simon Decker1, Christoph Kugler1
1Faculty of Life Sciences, Department of Pharmaceutical Sciences, Laboratory of Macromolecular Cancer Therapeutics (MMCT), University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
ACS applied materials & interfaces
|January 28, 2025
概括
这项研究引入了一种新的纳米载体,cLPEI,用于拼接切换的寡核酸 (SSO). 这种输送系统提高了SSO的生物可用性和 in vivo拼接校正的效率,克服了生物障碍,提高了治疗潜力.
科学领域:
- 在RNA治疗方面,RNA疗法.
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 拼接切换型寡核酸 (SSO) 通过调节RNA拼接,有望通过调节RNA拼接在疾病中恢复蛋白质功能.
- 有效的SSO体内传递仍然是一个挑战,限制了它们的治疗应用.
- 目前的传递载体经常面临稳定性,细胞吸收和内分体逃逸的问题.
研究的目的:
- 开发和评估一种新的生物相容纳米载体,用于增强SSO传递和体内拼接校正.
- 研究纳米载体克服生物障碍的能力,并提高SSO生物可用性.
- 在体内评估SSO装载纳米载体的治疗疗效和生物分布.
主要方法:
- 开发一个对氧化还原反应敏感的二硫化物交联低分子量线性聚乙烯胺 (cLPEI) 纳米载体,用于SSO.
- 在体外评估内体逃逸和拼接校正效率.
- 使用转基因小鼠模型进行拼接校正,生物分布分析和成像技术 (NIR光,CT) 的体内研究.
主要成果:
- cLPEI纳米载体在体外显示加速内体逃生和高效的核SSO释放,导致高拼接校正.
- 在cLPEI-SSOs的单次静脉注射剂量在体内诱导了多个器官 (肝脏,肺,脏,膀) 的显著拼接校正.
- 观察到改善了器官保留和减少了SSO的脏分泌,在胰腺瘤中积累.
- 证实了SSO在肝细胞中的核输送成功.
结论:
- 开发的cLPEI纳米载体系统显著提高了SSO的生物可用性和体内结合校正效率.
- 这种纳米载体技术代表了通过克服传递挑战来推进RNA向治疗的有希望的战略.
- 这些发现突出了纳米载体设计在SSO实现高效治疗结果的关键作用.
相关概念视频
01:32RNA Splicing
55.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.9K
02:18Alternative RNA Splicing
20.9K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.9K
02:27Nonsense-mediated mRNA Decay
10.5K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.5K
02:23RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K